Drug Trial Radar · NCT07524946
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Last checked: Nov 20, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Apr 1, 2026
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- MedTrials Incorporated
- First posted
- Apr 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 9 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to evaluate the safety, pharmacokinetics, and treatment effect for topically applied CABTREO lotion in pediatric participants ages 9 to 11 years, 11 months with Acne Vulgaris.
Conditions
- Acne Vulgaris
Interventions
CABTREO is a fixed-combination product of clindamycin phosphate 1.2%/BPO 3.1%/adapalene 0.15%.Drug
The study drug will be applied topically to the treatment areas at home, each the morning, for a period of 12 weeks, with the exception of study visit days (baseline \[Day 1\], and Days 14, 15 \[PK substudy only\], 28, 29 \[PK substudy only\], 56, and 84) where study drug will be applied by the participants after the study visit is completed at the study center. The study drug will be applied as a thin coating that is gently rubbed into the skin.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-Emergent Adverse EventsTime frame: All AEs will be followed from onset of the adverse event through the end of Study Week 12 visit
- Change in Inflammatory LesionsTime frame: Baseline through Week 12
- Change in Non-inflammatory LesionsTime frame: Baseline through Week 12
- EGSS ResultsTime frame: Baseline through Week 12
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Dermatology Trial Associates
Bryant, Arkansas · Recruiting
Northwest Arkansas Clinical Trials Center
Rogers, Arkansas · Recruiting
Center for Dermatology Clinical Research
Freemont, California · Recruiting
Ablon Skin Institute and Research Center
Manhattan Beach, California · Recruiting
Ziaderm Research, LLC
North Miami Beach, Florida · Recruiting
Clinical Research Trials of Florida, Inc
Tampa, Florida · Recruiting
DS Research of Kentucky, LLC
Louisville, Kentucky · Recruiting
Michigan Center for Skin Care Research
Clinton Township, Michigan · Recruiting
JDR Dermatology Research
Las Vegas, Nevada · Recruiting
DermResearchCenter of New York
Stony Brook, New York · Recruiting
Vitality Clinical Trials, LLC
Woodbury, New York · Recruiting
Flourish Research Acquisition, LLC
Apex, North Carolina · Not yet recruiting
Lynn Health Science Institute
Oklahoma City, Oklahoma · Recruiting
Cyn3rgy Research Corporation
Gresham, Oregon · Recruiting
Breakaway Research Group
Spokane, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.